Major Trial Finds Finerenone Slows Kidney Decline and Lowers Cardiovascular Risk in Non-Diabetic Chronic Kidney Disease
In a groundbreaking development in nephrology, the Phase III FIND-CKD trial has delivered compelling evidence that finerenone, a novel non-steroidal ...
